-
Varenicline: novel agent to help smokers quit. Current Psychiatry. 2025; 1(6):91-96.
Anthenelli RM.
-
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment. US multi-site randomized controlled trial. Arch Intern Med. 2025; 11(168):1188-1199.
Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait Daoud N, (and in alphabetical order) Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O’Malley SS, Swift RM, for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group (Anthenelli RM, member). View Publication.
-
The Uncomplicated Guide to Diabetes Complications. Smoking and Diabetes. 2025; 383-388.
Autry A, Anthenelli RM.
-
E-cigarettes and vapes: do they work for smoking cessation and should we be recommending their use?. Current Psychiatry. 2017; 5(16):31-39.
Gaznick N, Anthenelli RM.
-
Forget the myths and help your psychiatric patients quit smoking. Current Psychiatry. 2016; 10(15):23-25.
Anthenelli RM.
-
Psychiatric Aspects of Preventive Care: A Practical Guide for Healthcare Providers. Tobacco Dependence. 2015; 95-110.
Bekman, NM, Anthenelli RM.
-
Nicotine-Related Disorders. Gabbard's Treatment of Psychiatric Disorders. 2014; 871-884.
Anthenelli RM.
-
Varenicline not linked to depression, anxiety in smokers. Reactions. 2013; (1472):4-5.
Anthenelli RM.
-
Strategies to help patients break the chain`s of tobacco addiction. Current Psychiatry. 2011; 8(10):41-49.
Heffner JL, Anthenelli RM.
-
Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook. Genetic factors in the risk for substance use disorders. 2011; 36-54.
Nguyen TA, Heffner JL, Lin SW, Anthenelli RM.
-
Vaccine for cocaine addiction: A promising new immunotherapy. Current Psychiatry. 2010; (9):16-21.
Anthenelli RM, Somoza E.
-
Smoking cessation during substance abuse treatment: is it mission impossible?. Psychiatric Times. 2010; 9(26).
Heffner, JL, Anthenelli RM.
-
Psychiatric Times. Smoking cessation during substance abuse treatment: Is it mission possible?. 2009; 9(26):26-30.
Heffner JL, Anthenelli RM.
-
Future developments 1: CB1 blockade for weight gain subsequent to smoking cessation. Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk. 2009; 247-252.
Heffner JL, Anthenelli RM.
-
The neurobiology and treatment of tobacco dependence. Current Cardiovascular Risk Reports. Current Cardiovascular Risk Reports. 2008; (2):427-433.
Nguyen TA, Anthenelli RM. View Publication.
-
Antiepileptic Drugs to Treat Psychiatric Disorders. Antiepileptics as potential aids to smoking cessation. 2008; 271-282 .
Anthenelli RM, Heffner JL, Johnson CS.
-
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007; 14(298):1641-1651.
Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O’Malley SS, Swift RM; Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group (Anthenelli RM, member). View Publication.
-
Arch Intern Med. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. 2006; (166):1571-1577.
Oncken C, Gonzales D, Nides M., Rennard S., Watsky E., Billing CB, Anziano R., Reeves K. for the Varenicline Study Group (Anthenelli RM, member). View Publication.
-
Obesity and Mental Disorders. Obesity and smoking. 2006; 123-144.
Heffner JL, Winders-Barrett S and Anthenelli RM.
-
Medication Treatments for Nicotine Dependence. Cannabinoid antagonists: CB1 receptors as a therapeutic target for nicotine dependence. 2006; 187-198 .
Anthenelli RM.
-
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005; 13(293):1617-1625.
Garbutt JC, Kranzler HR, O’Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group (Anthenelli RM, member). View Publication.
-
Treating patients with bipolar disorder and COPD or asthma. Supplement to Current Psychiatry. 2005; (4):34-42.
Anthenelli RM.
-
Recent advances in the treatment of tobacco dependence. Clinical Neuroscience Research. 2005; (5):175-183.
Anthenelli RM. View Publication.
-
How – and why – to help psychiatric patients stop smoking. Current Psychiatry. 2005; 1(4):77-87.
Anthenelli, RM.
-
Substance Abuse: A Comprehensive Textbook. Genetic factors in the risk for substance use disorders. 2005; 33-47.
Lin SW, Anthenelli RM.
-
Naltrexone depot for treatment of alcohol dependence: A multi-center, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res. 2004; 7(28):1051-1059.
Kranzler HR, Wesson DR, Billot L for the Drug Abuse Sciences Naltrexone Depot Study Group (Anthenelli RM, member). View Publication.
-
Getting to the bottom of problem drinking: the case for routine screening. Current Psychiatry. 2003; 6(2):26-44.
Allen JP, Anthenelli RM.
-
An update on alcoholism. Psychiatric Update. 2003; 4(23):1-11.
Schuckit MA, Anthenelli RM, Guschwan MT.
-
Alcoholism and psychiatric disorders: diagnostic challenges. Alcohol Res & Health. 2002; 2(26):90-98.
Shivani R, Goldsmith RJ, Anthenelli RM. View Publication.
-
Neurobiological, Behavioral, and Environmental Relations to Drinking-Stress Hormone Dysregulation at Rest and After Serotonergic Stimulation Among Alcohol-Dependent Men With Extended Abstinence and Control. Alcoholism-Clinical and Experimental Research. 2001; 5(25):692-703.
Anthenelli RM, Maxwell RA, Geracioti Jr TD, Hauger RL.
-
Neurobiological, Psychosocial, and Developmental Correlates of Drinking-Cigarette Smoking Decreases the Prolactin Response to Serotonergic Stimulation in Subgroups of Alcoholics and Controls. Alcoholism-Clinical and Experimental Research. 2000; 7(24):987-95.
Anthenelli RM, Maxwell RA.
-
Principles of Addiction Medicine. Genetic influences in addiction. 1998; 17-35.
Anthenelli RM, Schuckit MA.
-
Substance Abuse: A Comprehensive Textbook. Genetics. 1997; 21-51.
Anthenelli RM, Schuckit MA.
-
Principles and Practice of Addictions in Psychiatry. A basic clinical approach to diagnosis in patients with comorbid psychiatric and substance use disorders. 1997; 119-126.
Anthenelli RM.
-
Hypothesized subtypes of alcoholism. Alcohol Research. 1995; 3(19):178.
Anthenelli RM, Tabakoff B.
-
Principles of Addiction Medicine. Genetic influences in addiction. 1994; 1-14.
Anthenelli RM, Schuckit MA.
-
The initial evaluation of the dual diagnosis patient. Psychiatric Annals. 1994; (24):407-411.
Anthenelli RM.
-
Comparison of the subjective and amnestic effects of diazepam and amobarbital in healthy young men. Am J Addictions. 1993; (2):131-140.
Anthenelli RM, Klein JL, Smith TL, Schuckit MA. View Publication.
-
The International Handbook of Addiction Behavior. Alcohol and cerebral depressants. 1991; 57-62.
Anthenelli RM, Schuckit MA.
-
Substance Abuse: A Comprehensive Textbook. Genetics. 1991; 39-50.
Anthenelli RM, Schuckit MA.